Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2014-12-23 Regulatory Filings
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings
2014-12-23 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a material definitive agreement amendment related to a loan and security agreement, including details about fees, loan amounts, and stock issuance. It also references the filing of exhibits to the annual report on Form 10-K but does not itself contain comprehensive financial statements or annual performance data. The document is not an annual report, earnings release, or management discussion but rather a regulatory filing announcing a financing amendment and related stock issuance. Therefore, it fits best under Regulatory Filings (RNS). The document length (6630 characters) and detailed content confirm it is not a brief announcement but a substantive regulatory filing. Confidence is high due to the clear identification as a Form 8-K and the nature of the content.
2014-12-18 English
PRIMARY DOCUMENT
Director's Dealing
2014-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2014-12-15 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 11, 2014, reporting the appointment of a new director to the Board of Directors of Insmed Incorporated. The content focuses on the increase in board size, appointment of Ms. Myrtle Potter as a director, her background, compensation, and independence determination. There are no financial statements or earnings data, no mention of annual or quarterly reports, no audit information, no voting results, no dividend announcements, and no merger or acquisition activity. The key item reported is the change in the company's board composition, which fits the category of Board/Management Information (MANG). The document length is about 4957 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the correct classification is MANG with high confidence.
2014-12-15 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions an "Other Events" section where the company announces a press release about an end of year regulatory and clinical update. The document is short (2746 characters) and primarily serves to notify the market of this event and attach the press release as an exhibit. There are no financial statements or detailed financial data included, nor is this a full annual or quarterly report. The nature of the filing is an announcement of an event rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2014-12-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.